References
- Goodwin FK: Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry 2003; 64\(suppl 5):18–24
- Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM: The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61:9–15
- Zarate CA Jr, Quiroz JA: Combination treatment in bipolar disor-der: A review of controlled trials. Bipolar Disord 2003; 5:217–225
- Ballenger JC, Post RM: Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978; 2:159–175
- Hirschfeld RM, Kasper S: A review of the evidence for carbam-azepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol 2004; 7:507–522
- Weisler RH, Kalali AH, Ketter TA, and the SPD417 Study Group: A multicenter, randomized, double-blind, placebo-con-trolled trial of extended-release carbamazepine capsules as mono-therapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:478–484
- Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA: Extended-release carbamazepine for treatment of manic and mixed symptoms. Presented at the 157th American Psychiatric Association Annual Meeting; May 1–6,2004; New York, NY
- Ketter TA, Kalali AH, Weisler RH, for the SPD417 Study Group: A 6-month, multicenter, open-label evaluation of extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:668–673
- Rapeport WG, McInnes GT, Thompson GG, Forrest G, Park BK, Brodie MJ: Hepatic enzyme induction and leucocyte delta-amino-laevulinic acid synthase activity: studies with carbamazepine. Br J Clin Pharmacol 1983; 16:133–137
- Ketter TA, Post RM, Worthington K: Principles of clinically important drug interactions with carbamazepine. Part I. J Clin Psychopharmacol 1991; 11:198–203
- Ketter TA, Post RM, Worthington K: Principles of clinically important drug interactions with carbamazepine. Part II. J Clin Psychopharmacol 1991; 11:306–313
- Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modi-fication of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73:159–171
- Freeman MP, Stoll AL: Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998; 155:12–21
- Grof P: Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J Clin Psychiatry 2003; 64\(suppl 5):53–61
- McElroy SL: Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry 2004; 65\(suppl 15):35–44